Notably, of four patients who relapsed post-HSCT, three relapsed with CD19+ disease and were able to receive CART therapy which induced another CR; one patient experienced a lineage switch to acute myeloid leukaemia (AML). The gene discussed is CD19; the disease is acute myeloid leukemia.